［1］Liu YJ,Yang CC.The fashion trend of lung cancer and the burden of disease in China［J］.Modern Trade and Industry,2016,2:212-213.［刘永军,杨婵婵.我国肺癌流行趋势及疾病负担概况［J］.现代商贸工业,2016,2:212-213.］
[2]Li A,Niu FY,Han JF,et al.Predictive and prognostic value of de novo MET expression in patients with advanced non-small-celllung cancer［J］.Lung Cancer,2015,90(3):375-380.
[3]Lu ZL，Ren WH,Jia WD,et al.The expression and significance of kinesin Eg5 in hepatocellular carcinoma ［J］.J Med University of Anhui,2012,47(9):28-30.［卢正磊,任维华,荚卫东,等.驱动蛋白 Eg5 在肝细胞癌中的表达及其意义［J］.安徽医科大学学报,2012,47(9):28-30.］
[4]Le Guellec R,Paris JF，Coutrier A,et al.Clonning by differential screening of a xenopus CDNA that encodes a kinesin-related proteint ［J］.Mol Cell Biol,1991,11(6):3395-3398.
[5]Kwok BH,Yang JG,Kapoor TM,et al.The rate of bipolar spindle assembly depends on the microtubule-gliding velocity of the mitotic kinesin Eg5［J］.Curr Biol,2004,14(19):1783-1789.
[6]Castillo A，Justice MJ．The kinesin related motor protein，Eg5，is essential for maintenance of pre-implantation embryogenesis［J］．Biochem Biophys Res Commun,2007,357(3):694-699．
[7]Castillo A,Morse HC,Godfrey VL,et al.Overexpression of Eg5 causes genomic instability and tumor formation in mice［J］.Cancer Res,2007,67(21):10138-10147.
[8]Liu L,Liu X,Mare M,et al.Overexpression of Eg5 correlates with high grade astrocytic neoplasm［J］.J Neuro Oncol,2016,126(1):77-80.
[9]Nowicki MO,Pawlowski P,Fischer T,et al．Chronic myelogenous leukemia molecular signature［J］.Oncogene,2003,22(25):3952-3963.
[10]Sun D,Lu J,Ding K，et al.The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma［J］.Med Oncol,2013,30(1):476.
[11]Chen JX.Expression of Eg5 and PCNA in human bladder carcinoma and its influence on the biological behavior of bladder cancer ［J］.J Med University of Anhui,2014,06（8):743-753.［陈杰勋.Eg5、PCNA在人膀胱癌组织的表达及其对膀胱癌组织生物学行为的影响［J］.安徽医科大学学报,2014,06(8):743-753.］
[12]Sun L,Lu J,Niu Z.A potent chemotherapeutic strategy with Eg5 inhibitor against gemcitabine resistant bladder cancer［J］.PLoS One,2015,10(12):0144484.
[13]Saijo T,Ishii G，Ochiai A，et al． Eg5 expression is closely correla ted with the response of advanced non-small cell lung cancer to an-timitotic agents combined with platinum chemotherapy［J］.Lung Cancer,2006,54(2):217-225.
[14]Liu X,Gong H,Huang K.Oncogenic role of kinesin proteins and targeting kinesin therapy［J］.Cancer Sci，2013,104(6):651-656.
[15]Luo XY,Zhang M,Liu J.Progress of kinesin Eg5 inhibitors in cancer research［J］.Chongqing Med J,2013,42(26):3172-3174.［罗兴燕,张梅,刘进.驱动蛋白Eg5抑制剂在肿瘤研究中的进展［J］.重庆医学,2013,42(26):3172-3174.］